The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Use of chemotherapy for patients with stage IV non-small cell lung cancer.
 
Sadaf Huma Waqar
No Relationships to Disclose
 
Saiama Naheed Waqar
Research Funding - Daiichi Sankyo (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Lilly (Inst); Newlink Genetics (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Spectrum Pharmaceuticals (Inst)
 
Siddhartha Devarakonda
No Relationships to Disclose
 
Feng Gao
No Relationships to Disclose
 
Cliff Grant Robinson
Research Funding - Varian Medical Systems
Travel, Accommodations, Expenses - Varian Medical Systems; ViewRay
 
Varun Puri
No Relationships to Disclose
 
Ramaswamy Govindan
Honoraria - Boehringer Ingelheim
Consulting or Advisory Role - Abbvie; Boehringer Ingelheim; Celgene; Clovis Oncology; Genentech/Roche; GlaxoSmithKline; Helsinn Therapeutics; Merck; Pfizer
Research Funding - Abbvie (Inst); Bayer (Inst); GlaxoSmithKline (Inst); MethylGene (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Celgene; Merck
 
Daniel Morgensztern
Honoraria - Boehringer Ingelheim; Boehringer Ingelheim
Consulting or Advisory Role - Celgene
Speakers' Bureau - Boehringer Ingelheim
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); GlaxoSmithKline (Inst); Heat Biologics (Inst); Merck (Inst); Verastem (Inst)